Brief: Catalyst Biosciences Sells Complement Portfolio For $60 Million
23/05/2022 14:21
May 23 (Reuters) - Catalyst Biosciences Inc CBIO.O :
* PRESS RELEASE - CATALYST BIOSCIENCES SELLS COMPLEMENT
PORTFOLIO
FOR $60 MILLION
Source text for Eikon: ID:nGNX2kBmZ4
Further company coverage: CBIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gyre Therapeutics
See all newsBrief: Gyre Therapeutics - Enters Employment Agreement With Ying Luo As CEO - SEC Filing
Gyre Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Gyre Therapeutics, Inc. expected to post a loss of 13 cents a share - Earnings Preview
Brief: Gyre Therapeutics Reports Second Quarter 2026
Gyre Therapeutics Q2 revenue beats estimates on higher ETUARY sales volumes